GlassScriptPhysician profile
Karen K Meyer
NPI 1255448759
$965.02
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $192 · 2020: $232 · 2021: $250 · 2022: $262 · 2023: $28.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $28.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $28.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $132.73 | 2019-2022 | |
| Novo Nordisk INC | $126.64 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $100.14 | 2020-2022 | |
| Otsuka America Pharmaceutical, INC. | $79.82 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $46.83 | 2021-2023 | Trintellix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $39.15 | 2020-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $31.82 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.76 | 2021 | |
| Amarin Pharma, INC. | $30.79 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $30.63 | 2020 | |
| Nalpropion Pharmaceuticals LLC | $27.43 | 2019 | |
| Tris Pharma INC | $26.85 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $26.81 | 2019 | |
| Genentech USA, INC. | $26.30 | 2022 | |
| Pfizer INC. | $25.68 | 2019-2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $24.11 | 2019 | |
| Boston Scientific Corporation | $15.91 | 2019 | |
| Circassia INC. | $15.80 | 2019 | |
| Sobi, INC | $15.59 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $15.55 | 2021 | |
| Antares Pharma, INC. | $15.22 | 2021 | |
| Ironshore Pharmaceuticals INC. | $14.15 | 2019 | |
| Merck Sharp & Dohme LLC | $13.99 | 2022 | |
| Axsome Therapeutics, INC. | $13.35 | 2023 | Auvelity |
| Bausch Health US, LLC | $12.95 | 2022 | |
| Sanofi Pasteur INC. | $12.94 | 2022 | |
| Glaxosmithkline, LLC. | $12.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.